Bright Minds Biosciences Inc.
DRUG | NASDAQ
$61.02
+$1.56 (+2.62%)
Sep 22, 2026, 1:12 PM ET · Market open
TTM Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -24.75M | -27.53M | -19.84M | -12.23M | -8.92M | -3.44M | -1.07M | -2.8M | -3.56M | -5.24M | -6.72M | -7.37M | -8.81M | -10.01M | -12.44M | -14.96M | -14.87M | -15.75M | -12.84M | -8.65M | -6.19M | -2.68M | -1.12M |
Depreciation & Amortization | 76.9K | 72.77K | 75.12K | 76.87K | 78.88K | 33.15K | 28.78K | 25.36K | 24.45K | 72.45K | 72.45K | 72.45K | 54.34K | 36.23K | 18.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 2.35M | 3.68M | 4.29M | 3.18M | 2.32M | 1.19M | 797.21K | 839.77K | 1.03M | 1.08M | 886.94K | 1.15M | 781.55K | 837.39K | 1.1M | 875.06K | 1.22M | 1.19M | 1.02M | 880.62K | 665.35K | 404.55K | 279.31K |
Other Working Capital | 1.23M | 2.09M | 53.8K | 917.84K | -287.88K | -636.92K | -636.62K | 53.06K | -395.37K | 42.38K | 467.5K | -1.06M | 196.63K | -165K | -47.42K | 769.77K | 119.95K | 781.18K | 308.38K | 416.23K | 130.87K | 82.97K | -15.15K |
Other Non-Cash Items | -3.1M | 2.49M | 2.79M | -276.84K | -829.1K | -1.6M | -1.62M | 46.82K | 226.42K | 90.89K | 97.26K | 65.1K | -143.37K | -13.2K | -16.88K | -221.36K | -332.4K | -43.43K | -61.72K | 144.76K | 297.17K | 3.97K | 15.24K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 420.1K | 1.2M | -322.82K | 554.99K | -543.28K | -317.24K | -658.6K | 39.81K | -308.93K | -477.5K | 481.74K | -941.72K | 157.4K | -21.96K | 43K | 724.13K | 133.5K | 641.52K | 159.19K | 306.08K | 83.65K | 126.4K | 43.43K |
Operating Cash Flow | -25M | -20.08M | -13.01M | -8.69M | -7.89M | -4.14M | -2.52M | -1.85M | -2.58M | -4.48M | -5.18M | -7.02M | -7.96M | -9.17M | -11.3M | -13.59M | -13.85M | -13.96M | -11.72M | -7.32M | -5.14M | -2.15M | -778.18K |
Capital Expenditures | -4.18 | -4.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.88K | -22.88K | -22.88K | -22.88K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.88K | -22.88K | -22.88K | -22.88K |
Debt Repayment | -52.14K | -77.76K | -102.39K | -100.15K | -97.9K | -94.24K | -91.56K | -89.73K | -87.52K | -87.05K | -86.58K | -86.11K | -39.63K | -18.14K | -28.65K | -7.16K | -32K | -32K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.7K | -9.7K | -9.7K | -9.7K | n/a | -10 | -10 |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -866.25K | -839.67K | -812.54K | -360.14K | -83.72K | -83.72K | -83.72K | n/a | n/a | n/a | n/a | 1.06M | 2.06M | 2.07M | 2.11M | 1.17M | 163.93K | -354.37K | -1.58M | -1.68M | -1.68M | -1.17M | 22.88K |
Financial Cash Flow | 277M | 279.19M | 46.92M | 85.57M | 52.23M | 52.22M | 51.97M | 810.57K | 812.48K | 812.95K | 813.42K | 2.19M | 7.28M | 7.31M | 7.33M | 5.2M | 122.23K | -435.32K | 24.28M | 26.06M | 26.99M | 27.53M | 2.9M |
Net Cash Flow | 249.52M | 252.25M | 31.15M | 77.19M | 45.2M | 49.75M | 51.14M | -1.03M | -1.94M | -3.74M | -4.45M | -4.88M | -510.2K | -1.8M | -3.91M | -8.13M | -13.37M | -13.98M | 13.01M | 18.96M | 21.92M | 25.38M | 2.09M |
Free Cash Flow | -25M | -20.08M | -13.01M | -8.69M | -7.89M | -4.14M | -2.52M | -1.85M | -2.58M | -4.48M | -5.18M | -7.02M | -7.96M | -9.17M | -11.3M | -13.59M | -13.85M | -13.96M | -11.72M | -7.32M | -5.14M | -2.15M | -778.18K |
Adj. Free Cash Flow | -27.35M | -23.76M | -17.3M | -11.87M | -10.21M | -5.33M | -3.32M | -2.69M | -3.61M | -5.56M | -6.07M | -8.18M | -8.74M | -10M | -12.4M | -14.46M | -15.07M | -15.15M | -12.74M | -8.2M | -5.81M | -2.55M | -1.06M |
Maintenance CapEx | -4.18 | -4.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -25M | -20.08M | -13.01M | -8.69M | -7.89M | -4.14M | -2.52M | -1.85M | -2.58M | -4.48M | -5.18M | -7.02M | -7.96M | -9.17M | -11.3M | -13.59M | -13.85M | -13.96M | -11.72M | -7.32M | -5.14M | -2.15M | -778.18K |
Add to Watchlist
Select watchlists to add or remove DRUG